Improving access to high-cost cancer drugs in Latin America: Much to be done: High-Cost Cancer Drugs in Latin America

    loading  Checking for direct PDF access through Ovid

Abstract

Limited access to high-cost cancer medications poses a significant threat to global health care, particularly for low- and middle-income countries. Systematic and transparent cost-effectiveness analyses are needed to devise equitable oncology drug pricing schemes.

See also pages 1292–7.

Related Topics

    loading  Loading Related Articles